We assembled a diverse panel of 75 immune ligands [41] and tested their antiviral activity against RVFV using a microscopy-based screening workflow, shown in Fig 2A, where we quantified nuclei, neurons (MAP2 positive cells), and infection (RVFV positive cells). Here, MAP2 is linked to infection.